Contemporary use of anticoagulation in the cardiac catheterization laboratory: a review

Brent J Klinkhammer1, Sandeep Nathan2, Ankitkumar K Patel1

  • 1Section of Cardiology, Hackensack University Medical Center, Hackensack, New Jersey.

Coronary Artery Disease
|August 19, 2021
PubMed

Insights

This review examines clinical trials and guidelines for anticoagulation during percutaneous coronary interventions (PCI). It discusses drug pharmacokinetics and future directions for anticoagulation therapy in coronary artery disease.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Anticoagulation is crucial for percutaneous coronary interventions (PCI).
  • Clinical trials have shaped current anticoagulation practices.
  • Optimizing anticoagulation improves patient outcomes and procedural safety.

Purpose of the Study:

  • To review significant clinical trials and guidelines for anticoagulation in the catheterization laboratory.
  • To discuss the pharmacological aspects and pharmacokinetics of commonly used anticoagulation agents.
  • To explore future directions in anticoagulation therapy for coronary artery disease.

Main Methods:

  • Review of landmark clinical trials.
  • Analysis of current clinical practice guidelines.
  • Discussion of pharmacokinetic properties of anticoagulants.

Main Results:

  • Established evidence base for anticoagulation in PCI.
  • Identification of specific scenarios where anticoagulation may not be needed.
  • Understanding of how pharmacokinetic parameters influence agent selection and monitoring.

Conclusions:

  • Anticoagulation choice impacts PCI outcomes.
  • Pharmacokinetic knowledge is essential for safe and effective anticoagulation.
  • Future research will refine anticoagulation strategies in coronary artery disease.

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
303
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
284
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.5K
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
306
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.1K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
65